Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global oral antidiabetic drug market is expected to reach USD 35.91 billion by 2022, growing at a CAGR of 10.2% between 2017 and 2022.

06-Jan-2017 | Number of pages: 110 | Report Code: ZMR-687 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oral antidiabetic drugs market on a global level.

In order to give the users a comprehensive view of the Oral antidiabetic drugs market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the oral antidiabetic drugs market has also been included. The study encompasses a market attractiveness analysis, wherein the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the oral antidiabetic drugs market by segmenting the market based on drugs class and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The drugs class segmentation includes sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. The meglitinides class is further segmented into repaglinide and nateglinide. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., Canada, China, Japan, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global oral antidiabetic drugs market include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer.

This report segments the global oral antidiabetic drugs Market as follows:

Global Oral Antidiabetic Drugs Market: Drugs Class Analysis

  • Sulfonylureas
    • Glimepiride
    •  Gliclazide
    •  Glyburide
    •  Others
  • Meglitinides
  • Repaglinide
  • Nateglinide
  • Biguanides
    • Metformin
    •  Others
  • Alpha-glucosidase inhibitors
    • Acarbose
    •  Voglibose
    •  Others
  • Others

Global Oral Antidiabetic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Pharmaceutical Contract Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2061 | Report Format:

Global Pharmaceutical Contract Packaging Market: Overview Outsourcing of the packaging activities to the third party manufacturers is pharmaceutical contract packaging. The drug manufacturing companies are taking the services of other packaging parties for the packaging of the drugs thus saving ...Read More

Ocular Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2060 | Report Format:

Global Ocular Implants Market: Overview Ocular implants are used for the medical surgeries that deal with the replacement of the injured eye or to increase the sharpness of the vision. Different types of implants are available in the market which can be used for the treatment of various eye diso...Read More

Balanced Salt Solution For Cell Culture Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2057 | Report Format:

Global Balanced Salt Solution For Cell Culture Market: Overview A combination or mixture of the inorganic salts is called the balanced salt solution and it is generally used as a carbohydrate for the energy source. The balanced salt solutions are used for maintaining the mammalian cells for a sh...Read More

Incretin-Based Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2051 | Report Format:

Global Incretin-Based Drugs Market: Overview When the blood glucose levels decrease a group of metabolic hormones is stimulated which is known as incretins. Incretin-based drugs include glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors which are the new grou...Read More

Dunnage Air Bags Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2030 | Report Format:

Global Dunnage Air Bags Market: Overview The packaging industry worldwide has projected a fabulous growth in the recent years. This has positively impacted the shipping and logistic company as there has been a tremendous rise in the logistics and transportation services. All these shipping and l...Read More

Choose License Type:
Latest Published Reports

View All Published Reports